Pet Pain Relief Market By Product Type (Topical Treatments {Creams, Gels, Ointments, Sprays}, Oral Medications {NSAIDs, Opioids, Steroids, Analgesics}, Supplements {Joint Supplements, Omega-3 Fatty Acids, Herbal and Natural Remedies}, Therapeutic Devices, Injectables), By Pet Type (Dog, Cat, Small Animals, Others), By Application (Arthritis, Injury Recovery, Chronic Pain, Acute Pain), By Distribution Channel (Veterinary Clinics, Pet Stores, E-commerce, Others), By End-user (Pet Owners, Veterinarians, Animal Hospitals, Pet Shelters, Pet Care Centers, Pet Groomers.), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Pet Pain Relief market accounted for USD 1.43 Billion in 2024 and is expected to reach USD 2.95 Billion by 2035, growing at a CAGR of around 6.8% between 2025 and 2035. The Pet Pain Relief Market encompasses pain relief products for pets, specifically dogs, cats, and exotic animals. These pain relief products serve the purpose of already having been in use for millions of years to help manage chronic pain or acute pain due to varied conditions such as arthritis, injuries, post-surgery, and numerous other health problems. Available treatments in the market include topical pain relievers (creams, gels, and sprays); oral pain medications (non-steroidal anti-inflammatory drugs or NSAIDs, opioids, and analgesics); supplements for health support (joint support or omega-3 fatty acids); and therapeutic devices for heat therapy, laser therapy, or the like. Injectables provide the targeted pain relief required, too.

The attention given to aberrant animal pain relief increases with the progressive awareness of companion animal health and the attempt to ameliorate their quality of life. This market is driven by a combination of increasing numbers of pet ownership, increasing awareness regarding pet health, and rising demand for more advanced and specialized treatments for pets. Distribution channels include veterinary clinics, pet stores, e-commerce, and direct sales to hospitals and centers. In general, the Pet Pain Relief Market will be strong and expand in the future, with an increasing number of new products that are safer and more effective to meet the demand brought about by raising pet health care issues and advances in veterinary science. 

Report Scope:

Market Dynamics

Increased awareness about pet health and pain management.

Rising knowledge about pet healthcare and pain management strategies underscores the main force behind the Pet Pain Relief Market. An increasing awareness regarding pet well-being among pet owners creates heightened attention toward sufficient care, which now includes proper pain management for injuries and arthritis and other health-related pain. The enhanced awareness about pet health issues has initiated strong market traction for pain relief products, which now include both pharmaceutical drugs and nutritional supplements and therapeutic equipment. The increase in pet insurance programs now allows veterinarians to offer better access to prompt medical care for pets. The American Pet Products Association (APPA) conducted a study in 2022 showing that routine veterinary visits reached 70% of U.S. pet owners, and this includes pain management care, which demonstrates rising pet owner concern for animal health. Advanced pain relief solutions for pets are increasing because of shifting pet-owning attitudes toward veterinary medical care.

Rise in chronic health conditions like arthritis in pets.

A growing prevalence of chronic health conditions, especially arthritis in pets, creates an important requirement for the Pet Pain Relief Market. Older pets encounter a greater risk of developing chronic diseases that mostly affect their joints and cause both pain and uncomfortable conditions. Patients with arthritis experience major mobility complications, which leads their owners to look for suitable pain relief solutions to improve their pets' well-being.

A growing number of these health conditions in pets drives the need for anti-inflammatory medication along with joint supplements and alternative therapeutic solutions. Research from the American Veterinary Medical Association (AVMA) in 2021 indicates that arthritis exists in 20% of U.S. dogs, thus showing its common occurrence throughout the country. Pet owners have started to purchase pain management therapies for their animals' chronic issues as society becomes more informed about these treatments, which expands the market.

High cost of specialized pain relief treatments.

Costly treatments used for specialized pain relief care can be a hindrance in the Pet Pain Relief Market. Treatments like injectable medications, laser therapies, and other techniques can quickly become expensive with several treatments or very specialized devices; this may limit uptake for even economically moderate families, as pet owners may have several animals to treat. The costliest would-be long-term treatments of chronic conditions such as arthritis.

Some pet owners find it hard to maintain consistency in caring for pets as the costs continue to add up to some significant amounts. Many treatments are not included in cost-industry pet insurance. Out-of-pocket costs are incurred for any credits to the pet insurance account. All this limits proper adoption of such advanced pain-reduction methods primarily where economic access is less or where consultation for veterinary care is less.

Development of innovative, non-invasive pain relief devices for pets.

The Pet Pain Relief Market provides substantial business potential for developing innovative, non-invasive pain treatment devices for animals. The Pet Pain Relief Market benefits from effective non-surgical pain management through the use of laser therapy and TENS along with cold therapy systems. These medical devices give owners two essential benefits: security combined with ease of use for managing arthritis and post-surgical pain in their pets.

Market demand for these devices will rise due to the increasing number of pet owners who prefer natural options without using chemicals. Wearable devices designed to monitor and deliver pain relief treatments will expand the market through their ability to offer at-home management solutions that improve convenience for pet owners. Alternative therapies, along with technological approaches, will develop the direction of future pet pain management practices according to increasing owner interest.

Rising demand for personalized pet healthcare solutions.

The use of personalized pet healthcare solutions represents a major opportunity for the Pet Pain Relief Market. Pet owners search for individualized medical solutions that match their pets' particular health requirements, including the necessity of pain treatment. Personalized care approaches allow healthcare providers to address pain management more precisely through characteristics such as breed, age, weight, or pain type.

Modern veterinary medical advances enable gene tests, health tracking methods, and data analytics to develop individual veterinary treatment strategies for pets. Several personalized pain relief products, including custom supplements together with specialized medications and therapeutic devices, have prompted a market surge due to pet owner interest in pet healthcare. Companies now have a substantial market opportunity to create novel solutions that address specific veterinary requirements, thus achieving better pain control measures and enhanced lifestyle quality for pets.

Industry Experts Opinion

"Pets often hide their pain, which can make it difficult for owners to notice. Regular check-ups, especially for senior pets, are key to detecting pain early and managing it through a combination of methods such as prescription pain relievers, joint supplements, and lifestyle changes."

• Dr. Julie Buzby, DVM, Certified Veterinary Pain Practitioner

Segment Analysis

Based on the product type, the Pet Pain Relief Market has been classified into Topical Treatments, Oral Medications, Supplements, Therapeutic Devices, and Injectables. The Pet Pain Relief Market features oral medications as its most important and substantial product type. Veterinarians commonly use NSAIDs, opioids, and steroids along with analgesics as oral medications to treat short-term and long-lasting pain conditions in pets. These pharmaceutical medications deliver specific pain relief for pets who suffer from arthritis, along with those undergoing injury recovery and postoperative pain. The simplified method of administration and quick effect times establish oral medications as the preferred treatment for veterinarians and their pet patients. The increased occurrence of pet arthritis is pushing up the demand for these medicines. Among all treatment options, including topical applications and supplements, the primary role remains with oral pain medications due to their established clinical success and widespread veterinary practice costs.

Based on the Application, the Pet Pain Relief Market has been classified into Arthritis, Injury Recovery, Chronic Pain, and Acute Pain. The Chronic Pain application stands as the dominant segment among all applications in the Pet Pain Relief Market. The prevalence of chronic pain increases in pets because of long-term diseases, which include arthritis, hip dysplasia, and intervertebral disc disease during their aging process. Persistent pet pain disrupts normal life activities and mobility as well as quality of life, thus driving continuous pain management solution requirements. The continued treatment of persistent pain involves sustained approaches utilizing oral medications as well as supplements together with therapeutic medical equipment. The rising recognition of prolonged animal pain, together with its slow-developing consequences, has triggered an elevated need for market-based innovative remedies. The market growth for pet pain relief is strongly influenced by chronic pain management since pet owners and veterinarians have made it their principal concern.

Regional Analysis

The North American Pet Pain Relief Market maintains substantial importance because of both substantial pet population numbers and rising pet health consciousness levels. The pet populations of the United States and Canada grow substantially while both nations advance their focus on delivering quality healthcare alongside effective pain management solutions for their animal companions. The demand for pain relief products increases because arthritis is prevalent among pets, particularly aging animals. The region demonstrates a growing availability of advanced treatment options that encompass prescription drugs and therapeutic equipment and natural remedy options.

The rising number of veterinary clinics, together with expanding online pet product retailers, grants wider access to pain relief products. The expansion of the North American pet market continues because pet owners actively pursue better pet healthcare management. The market expands because pet healthcare insurance plans currently offer pain management coverage to pet owners. Australia ranks as a key market because of high pet spending combined with a robust veterinary system, thus establishing its leading position in the pet pain relief industry.

Pet pain relief market growth in the Asia Pacific region increases because pet ownership numbers are rising throughout China, Japan, and India. The increasing practice of looking at pets as family members drives up the need for efficient pain management solutions. The prevalence of recurring problems such as arthritis as well as injuries that require healing post-surgical operations continues to increase, thus raising the necessity for pain relief products. Market expansion for pet pain relief occurs because people now understand the importance of pet health while urban areas continue to build their infrastructure of veterinary clinics and pet care centers.

Pet owners favor plant-based pain relief techniques such as herbal remedies and nutritional supplements because they want safer alternatives for their pets within the region. The pricing sensitivity in developing markets creates difficulties as customers want affordable options. The online shopping sector establishes direct access to pet pain relief products for consumers. The future growth of the Pet Pain Relief Market within the Asia Pacific region shows promise because the regional pet healthcare market shows continuous development.  

Competitive Landscape

The Pet Pain Relief Market includes pharmaceutical giants alongside newer entities that aim to introduce innovative approaches alongside alternative medical options. The market leadership position remains with Zoetis Inc. along with Boehringer Ingelheim and Elanco Animal Health because these companies offer various pain relief solutions, including NSAIDs, opioids, and injectable solutions. The pet healthcare market demands diverse solutions, so these organizations invest in both non-handling pain relief machinery and natural health remedies, including joint nutritional supplements and Omega-3 fatty acids.

The pharmaceutical industry's growth strategy includes mergers acquisitions, which assist organizations in developing their product lines and extending their market reach. Market growth persists; however, rising prices in developing areas combined with regulatory obstacles that hinder new medication approvals create market challenges. Significant market expansion opportunities present themselves because of pet owners' growing emphasis on veterinary care and pain management versus the advancing field of pet health.

Pet Pain Relief Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In February 2025, Zoetis updated the U.S. label for Librela (bedinvetmab injection), a treatment for canine osteoarthritis pain, following reports of adverse events, including seizures and, in some cases, death. The label now includes a "Post Approval Experience" section detailing potential neurologic, urinary, and gastrointestinal side effects.

Report Coverage:

By Product Type

• Topical Treatments
  • Creams
  • Gels
  • Ointments
  • Sprays
• Oral Medications
  • NSAIDs
  • Opioids
  • Steroids
  • Analgesics
• Supplements
  • Joint Supplements
  • Omega-3 Fatty Acids
  • Herbal and Natural Remedies
• Therapeutic Devices
• Injectables

By Pet Type

• Dog
• Cats
• Small Animals
• Others

By Application

• Arthritis
• Injury Recovery
• Chronic Pain
• Acute Pain

By Distribution Channel

• Veterinary Clinics
• Pet Stores
• E-commerce
• Others

By End-user

• Pet Owners
• Veterinarians
• Animal Hospitals
• Pet Shelters
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Zoetis Inc.
• Boehringer Ingelheim International GmbH
• Vetoquinol SA
• Elanco Animal Health
• Mars Petcare
• Nestlé Purina Petcare
• Aratana Therapeutics, Inc.
• Hapilabs
• Patterson Companies, Inc.
• VetriScience Laboratories
• PetMed Express, Inc.
• Bayer Animal Health
• Pets Best
• Zomedica Pharmaceuticals Corp.
• Dechra Pharmaceuticals

Frequently Asked Questions (FAQs)